Your browser doesn't support javascript.
loading
Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator.
Sow, Samba O; Tapia, Milagritos D; Chen, Wilbur H; Haidara, Fadima C; Kotloff, Karen L; Pasetti, Marcela F; Blackwelder, William C; Traoré, Awa; Tamboura, Boubou; Doumbia, Moussa; Diallo, Fatoumata; Coulibaly, Flanon; Onwuchekwa, Uma; Kodio, Mamoudou; Tennant, Sharon M; Reymann, Mardi; Lam, Diana F; Gurwith, Marc; Lock, Michael; Yonker, Thomas; Smith, Jonathan; Simon, Jakub K; Levine, Myron M.
Afiliación
  • Sow SO; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Tapia MD; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Chen WH; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Haidara FC; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Kotloff KL; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Pasetti MF; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Blackwelder WC; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Traoré A; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Tamboura B; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Doumbia M; Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Diallo F; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Coulibaly F; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Onwuchekwa U; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Kodio M; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Tennant SM; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Reymann M; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Lam DF; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Gurwith M; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Lock M; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Yonker T; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Smith J; Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Simon JK; PaxVax, Inc., Redwood City, California, USA.
  • Levine MM; PaxVax, Inc., Redwood City, California, USA.
Clin Vaccine Immunol ; 24(12)2017 12.
Article en En | MEDLINE | ID: mdl-29021299
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cólera / Vacunas Atenuadas / Cólera / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Clin Vaccine Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2017 Tipo del documento: Article País de afiliación: Mali
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cólera / Vacunas Atenuadas / Cólera / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Clin Vaccine Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2017 Tipo del documento: Article País de afiliación: Mali